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Abstract: Several groups have demonstrated that it is possible to obtain long-term graft survival of con- 
cordant xenografts. One of the important questions that remains is whether xenografts are susceptible to 
chronic rejection. To answer this question we used the aorta transplantation model. One centimetre of 
hamster aorta was interposed in the abdominal aorta of Lewis rat recipients. The recipients were either 
untreated (group 1). or treated with lOmg/kg cyclosporine (CsA), given intramuscularly three times a 
week (group 2). Rats were sacrificed at day 7, 14, 21, 28, 56 and 84 and the thickness of the intima, the 
media and the adventitia was measured. Furthermore, the cellularity of the media and the adventitia was 
assessed by counting the number of nuclei per 0.05 mm* and immunohistochemistry of the aortic grafts 
was performed. Graft arteriosclerosis developed in aortic xenografts of both group 1 and group 2. In 
group 1, intimal lesions were already present from day 21 onwards in all rats, whereas in group 2 they 
were present only in 33% (2/6) of the rats. At day 84 all the grafts in group 1 were totally occluded, 
while those in group 2 were still open. The thickness of the media was slightly increased in both groups 
during the whole observation period, mainly due to edema. Although a few infiltrating macrophages could 
be seen, the number of nuclei per 0.05 mm* of the media remained constant during the first 21 days, but 
declined sharply from day 21 onwards, as a consequence of disappearing myocytes. Thickness of the 
adventitia in both groups increased after transplantation due to infiltrating macrophages and T cells, reach- 
ing a peak at day 14. After day 14 the adventitial thickness in group 1 decreased rapidly to reach values 
comparable to group 2 from day 28 onwards. 
In conclusion, graft arteriosclerosis, as a sign of chronic rejection, occurs in concordant aortic xeno- 
grafts. The lesions in the xenografts develop extremely rapidly, and, compared to data from the literature, 
faster than in aortic allografts. The process of chronic rejection in aortic xenografts can be reduced by CsA. 
Introduction 
In the past 10 years rapid progress has been made in under- 
standing and controlling the rejection of concordant xeno- 
geneic grafts. In 1987, Knechtle et al.’ were the first to achieve 
survival of more than 100 days in the concordant hamster- 
to-rat heart transplantation model. Therapy consisted of total 
lymphoid irradiation combined with cyclosporine (CsA). Their 
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findings have been confirmed by other groups using various 
therapeutic protocols. 24 Later it was demonstrated in the cyn- 
omolgus monkey-to-baboon heart transplantation model that 
survival of more than 1 year could be achieved5 Due to these 
promising results, clinical xenotransplantation has been perfor- 
med on a small scale.6 
The question now arises whether xenografts will be suscep- 
tible to chronic rejection. Chronic rejection is becoming a 
major obstacle of long-term allograft survival. Although it has 
many histological and clinical appearances, depending on the 
type of graft, most investigators agree that the prime manifes- 
tation common to all is transplant arteriosclerosis associated 
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with (and most likely due to) an ongoing immune response and 
inflammation in the graft. 7*8 Because the problem of chronic 
rejection has been perceived as secondary in importance to 
the control of powerful xenogeneic immune responses, it has 
received little experimental attention. Reemtsma et al. reported 
graft arteriosclerosis in renal arterioles in their 9-month surviv- 
ing patient with a chimpanzee kidney.9 They also found such 
lesions in heterotopically transplanted xenogeneic heart grafts 
in the cynomolgus monkey-to-baboon model. In this model 
intimal proliferation could already be demonstrated 6 days 
after transplantation, and was prominent 70-80 days after 
transplantation. Bailey ef al. demonstrated signs of chronic 
rejection in lamb hearts transplanted orthotopically in newborn 
goats. lo In all except one host they found histological abnor- 
malities in the grafts, ranging from moderate chronic rejection 
to severe subacute and chronic rejection 24-165 days after 
transplantation. 
Apart from these two reports, we know little about the sus- 
ceptibility of xenogeneic grafts to chronic rejection. In an 
effort to extend our understanding of vascular lesions in 
(concordant) xenografts, we have adapted the aorta transplan- 
tation model, which is widely used to examine chronic rejec- 
tion of allograft~,“-~~ to study chronic rejection of xenografts. 
In this article we describe the development of graft arterio- 
sclerosis in hamster aortas transplanted into non-immunosup- 
pressed and CsA-treated rats. 
Materials and methods 
Experimental design 
Recipient rats were divided into two groups after receiving an 
aortic xenograft. Rats in group 1 received no treatment (control 
group), whereas rats in group 2 received CsA three times a 
week, intramuscularly, in a dose of 10 mg/kg bodyweight. At 
day 7, 14, 21,28,56 and 84, four to eight rats from each group 
were sacrificed and the grafts were removed for histology or 
immunohistochemistry. 
Animals 
Male Syrian hamsters (outbred) were used as donors and male 
Lewis rats (RTI’) as recipients of aortic grafts. All animals 
were obtained from Harlan CPB (Austerlitz, The Netherlands). 
Hamsters weighed between 75 and 115 g and rats between 250 
and 350 g when used. The experimental protocols adhered to 
the rules laid down in the Dutch Animal Experimentation Act 
(1977) and the published Guidelines on the Protection of 
Experimental Animals by the Council of the EC (1986). The 
specific protocol was approved by the Committee on Animal 
Research of the Erasmus University Rotterdam, The Nether- 
lands. 
Aorta transplantation 
Aorta transplantation was performed as described by Men- 
nander et al.” Briefly, a segment of descending thoracic aorta 
of approximately 1 cm was removed from the hamster donor 
after animals were anticoagulated with 50 IU intravenous hep- 
arin (Organon Teknika, Boxtel, The Netherlands). The aorta 
segments were flushed with phosphate-buffered saline (PBS, 
0.01 M, pH 7.4), placed in chilled PBS and later used as a 
transplant. Recipient rats were anaesthetized with ether where- 
after a laparotomy was performed. The graft was transplanted 
into a heterotopic position below the renal arteries and above 
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the bifurcation. End-to-end anastomoses were performed with 
9-O monofilament nylon sutures (B. Braun-SSC, Neuhausen 
am Rheinfall, Switzerland). Total ischaemic time ranged from 
30 to 45 min, 10-15 min of which was cold ischaemia. The 
grafts were removed at 7, 14, 21, 28, 56 and 84 days after 
transplantation and were processed for histology or for frozen- 
section immunohistochemistry. 
Histology 
For evaluation of morphological changes, paraffin sections 
were stained with haematoxylin-eosin or elastin. Straight 
cross-sections of 5 pm were prepared from the centre of the 
graft to avoid the effects of the suture line. Slides were then 
examined by light microscopy for the following variables: the 
thickness of the different layers of the aorta (i.e. the adventitia, 
media, and intima, separated from each other by the external 
and internal elastic laminas, respectively) and the number of 
nuclei per 0.05 mm2 of the media and adventitia. Thickness 
was measured with a calibrated ocular micrometer and was 
calculated by dividing the sum of the largest and smallest 
thickness by two. Furthermore, the grafts were scored blindly 
by a pathologist for various parameters uch as normality of 
endothelial cells and presence of oedema. 
Immunohistochemistry 
For immunohistochemistry, 5 km thick frozen cross-sections 
were stained by the immunoperoxidase technique with the fol- 
lowing monoclonal antibodies: ER-1 to CD5 (all T cells, con- 
centration 1:4000); ER-2 to CD4 (T helper lymphocytes, mac- 
rophages and monocytes weakly, concentration 1:4000); OX8 
to CD8 (T cytotoxic and suppressor lymphocytes, NK (natural 
killer) cells, concentration 1:8000); OX6 to Ia antigen (non- 
polymorphic, concentration 1:8000); ED- 1 to monocytes, mac- 
rophages and dendritic cells, concentration 1:40) and HIS-14 
to B lymphocytes (concentration 1:500). Staining without pri- 
mary antibody (PBS) served as negative control. Furthermore, 
paraffin sections of 5 pm were stained with an anti-ol-actin 
monoclonal antibody (Biogenex, Duiven, The Netherlands, 
concentration 1:lOO) that demonstrates mooth muscle cells. 
The thawed sections were fixed with acetone (Merck, Darm- 
stadt, Germany). Directly after fixation for 10 min, the sections 
were washed for 10 min in PBS. Endogenous peroxidase was 
inhibited by incubation with 0.5% H202 for 10 min. The sec- 
tions were then washed for 10 min in PBS containing 0.2% 
bovine serum albumin (PBWBSA). The mouse anti-rat mono- 
clonal antibodies diluted in PBS/BSA were incubated for 1 h 
at room temperature. As second step antibody, peroxidase-con- 
jugated rabbit immunoglobulin to mouse immunoglobulins 
(P161; Dakopatts, Denmark) was used in a 1:200 dilution in 
PBS/BSA with 1% normal rat serum to minimize background 
staining. After 45 min of incubation at room temperature, the 
substrate was added for 5 min at room temperature. As sub- 
strate, 3,3’-diaminobenzidine tetrahydrochloride (Sigma, 
St Louis, USA) 0.05% (w/v) dissolved in 0.1 M acetate buffer 
(pH 6.0) with imidazole (0.07% (w/v); Merck), NiS04.6H20 
and 0.01% H202, as described by Green et al.,“’ was used. 
Positive cells are stained black. Sections were evaluated and 
results were expressed as 0 (no positive cells) to 3 (maximum 
number of positive cells). 
Cyclosporine 
CsA (Sandimmune; Sandoz, Basel, Switzerland) was dissolved 
in olive oil (OPG-Pharma, Utrecht, The Netherlands) to a con- 
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centration of 50 mg/ml and administered intramuscularly in a 
volume of 0.05-0.07 ml. 
Haemagglutination test 
Sera of experimental animals were serially diluted with 
Haemaccel (Behringwerke, Marburg, Germany) in a 96-well 
plate (Costar, Cambridge, UK) to an end volume of 50 ~1. 
Thereafter, 50 ~1 of a 2% hamster erythrocyte suspension was 
added and the plates were incubated for 60 min at 37T. The 
highest dilution at which agglutination could be observed was 
taken as antibody titre. 
Statistics 
Data of thickness and the number of nuclei per 0.05 mm2 are 
expressed as mean f SEM. Statistical comparisons between 
the control group and the CsA-treated group were performed 
using the Mann-Whitney U-test. For all data P < 0.05 was 
considered significant. 
Results 
For evaluating the progress of vascular alterations in the two 
treatment groups, 70 transplants were performed successfully. 
The number of rats in group 1 on days 7, 14, 21, 28, 56 and 
84 was, respectively, 6, 5, 5, 5, 4 and 6, and, in group 2, 6, 
8, 6, 6, 7 and 6. 
Histology 
Graft arteriosclerosis developed in aortic xenografts of both 
group 1 and group 2 (Figure 1). In group 1, intimal lesions 
could already be demonstrated at day 14 in 20% (l/5) of the 
rats and from day 21 onwards in all rats, whereas in group 2 
they were present only in 33% (2/6) of the rats at day 21. 
From day 56 the difference in intimal thickness between both 
groups was statistically significant (day 56: P < 0.01; day 84: 
P < 0.05). At day 84 all the grafts in group 1 were totally 
occluded, while those in group 2 were still open. During the 
first 4 weeks, 25 of 27 grafts were extensively (more than 67% 
circumference) or totally denuded. In the weeks thereafter the 
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Figure2 Thickness of the media (in pm + SEM) at various time 
points in group 1 (- ) and group 2 (---) 
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Figure 1 Thickness of the intima (in pm f SEM) at various time 
points in group 1 (- ) and group 2 (- - -). At day 56 and day 84 
the differences in thicknesses between both groups were statistically 
significant (*P < 0.01 and *P < 0.05 respectively). All grafts in group 
1 were totally occluded at day 84. 
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grafts were lined with high endotbelium. Between days 28 and 
84 new endothelium appeared. In group 1 all grafts (6/6) con- 
tained endothelial cells with enlarged nuclei until day 84, 
while in group 2 the endothelial nuclei were normal again at 
day 84 in 67% (416) of the grafts. 
The thickness of the media was slightly increased in both 
groups, mainly due to oedema, associated with or caused by 
the inflammation (Figure 2). Thickness of the media in group 
2 was normal again at day 84. 
Although a few infiltrating macrophages could be seen, the 
number of nuclei per 0.05 mm* in the media remained constant 
during the first 21 days, but declined sharply from day 21 
onwards as a consequence of migration or necrosis of myo- 
cytes (Figure 3). The decline in cell density coincided with the 
development of the intimal lesions. Destruction of the elastic 
laminae was predominantly found after day 28, especially in 
group 1. Group 2 showed only focal degeneration of the elastic 
laminae, whereas circumferential degeneration was seen in 
group 1. 
Thickness of the adventitia in both groups increased after 
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Figure 3 The number of nuclei per 0.05 mm2 (zt SEM) of the media 
at various time points in group 1 ( -)andgroup2(---) 
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Figure 4 Thickness of the adventitia (in p,rn Z!Z SEM) at various time 
points in group 1 (- ) and group 2 (- - -). At day 14 the differ- 
ence in thickness between both groups was statistically significant 
(*P < 0.01). 
transplantation, reaching a peak at day 14 (Figure 4). The 
thickness of the adventitia of a non-transplanted hamster aorta 
was 35 + 15 pm. Peak value of the adventitial thickness in 
group 1 was 1216 f 124 pm at day 14 while that in group 2 
was 560 f 296 p,rn (P C 0.01). The increase in thickness of 
the adventitia was mostly due to a cellular infiltrate of 
inflammatory cells and to concomitantly occurring oedema. 
After day 14 the adventitial thickness in group 1 decreased 
rapidly to reach values comparable to group 2 from day 28 
onwards. Adventitial thickness in both groups remained 
increased until the end of the experiment at day 84 (group 1: 
337 ?I 128 pm; group 2: 376 f 85 km, not-significant). 
The number of nuclei per 0.05 mm2 in the adventitia of both 
groups increased rapidly after transplantation (Figure 5). 
Maximal values in both groups were reached at day 14, where- 
after they declined steadily until day 56. From day 56 the num- 
ber of nuclei per 0.05 mm2 remained constant in both groups. 
There was no difference in cell density of the adventitia in 
both groups during the 84-day observation period, although 
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the total number of infiltrating cells was larger in group 1 (cell 
density x area). 
Figure 6 shows how the process of cellular infiltration and 
intimal proliferation developed in aortic grafts in the control 
group* 
(4 
(B) 
-I 
Figure 5 The number of nuclei per 0.05 mm2 (i SEM) of tbe 
adventitia at various time points in group 1 ( -_) and group 2 
(---) 
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Figure 6 Development of intimal lesions in aortic grafts in the control 
group on day 28 (A), day 56 (B) and day 84 (C) after transplantation. 
Haematoxylin-eosin stain, x50. Open triangle: internal elastic lamina; 
closed triangle: external elastic lamina. 
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ImmunohSstochemistry 
The subclasses of infiltrating leucocytes in the grafts were 
examined by immunoperoxidase staining. The cells infiltrating 
the adventitia were mainly T cells and macrophages. 
Occasionally B-cells could be demonstrated. No consistent dif- 
ferences were seen between the number of CD4+ and CD8’ 
cells throughout he observation period. There was no differ- 
ence between group 1 and group 2 concerning the type of 
infiltrating cells. However, the number of infiltrating cells was 
higher in group 1 at day 14 and declined thereafter to reach 
values comparable to group 2 from day 28 onwards. Cells 
infiltrating the media consisted mainly of macrophages. 
Occasionally, a few T cells could be seen, being either CD4+ 
or CD8’. No B cells could be demonstrated. At the end of the 
observation period no infiltrating cells were seen in the media 
of group 2 while very few macrophages were present in the 
media of group 1. 
The intima was infiltrated with macrophages and some T 
cells. In group 2 the number of infiltrating cells declined 
towards day 84; at that time hardly any infiltrating immune 
cells could be demonstrated. In group 1 the same tendency 
could be seen but especially the number of macrophages at 
day 84 was higher than in group 2, possibly associated with 
more necrosis being present at that time. It appeared that the 
intima consisted mainly of smooth muscle cells as shown by 
an antibody directed to smooth muscle cell actin. With this 
staining it could be demonstrated that cellular loss in the media 
was a consequence of disappearing smooth muscle cells. 
Antibody titre 
In group 1 haemagglutinating antibodies were measurable 
from day 7 onwards. The highest titre was reached at day 14 
(titre l/8). From day 14 until day 56 the antibody titre in group 
1 remained constant. At day 84 no antibodies could be demon- 
strated anymore. No antibodies could be found in group 2 dur- 
ing the whole observation period. 
Discussion 
In this study we demonstrate the development of graft arterio- 
sclerosis in concordant aortic xenografts. The development of 
the vascular lesions was highly reproducible, making this aorta 
transplantation model reliable to study signs of chronic rejec- 
tion of xenografts. As in the aortic allograft model, no immu- 
nosuppression is needed to obtain long-term graft survival.“-‘3 
This surprised us, because we had expected that the aortic 
xenografts would be destroyed quickly by host immune 
responses. Instead, the grafts remained viable, although they 
were infiltrated heavily. That aortic xenografts can remain 
viable for some time has, however, been reported earlier in 
studies of ‘classical’ atherosclerosis. One of the recently used 
models to study recanalization of atherosclerotic vessels is the 
transplantation of human atherosclerotic aorta into rabbit or 
dog recipients. 15-” Even in these discordant combinations, the 
aortic grafts are not destroyed hyperacutely. Thus, aortic grafts 
seem to be less susceptible to end-stage rejection than other 
vascularized grafts, possibly due to their size or to the high 
blood velocity within these grafts. 
The way the intimal lesions developed in our hamster-to- 
rat model mimicked the situation in the allogeneic aorta trans- 
plantation model.“-‘3,‘8 In both models the aortic graft 
becomes infiltrated with macrophages, T cells and occasion- 
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ally a few B cells. After this cellular infiltration of especially 
the adventitia, a progressive intimal thickening, made up prim- 
arily of smooth muscle cells, follows. Whether the intimal 
proliferation is caused by the infiltration cells, cannot be. 
concluded from this experiment. In the allogeneic aorta trans- 
plantation model in the rat, a clear correlation exists between 
the degree of cellular infiltration and the severity of the art- 
eriosclerotic lesions.19 This has also been demonstrated in rat 
heart allografts. Cramer et al. concluded that, based upon the 
ability to modify the lesions by immunization and T cell spec- 
ific immunosuppression, the arteriosclerotic hanges in this 
heart allograft model were likely a chronic cell-mediated rejec- 
tion response. *O In the xenogeneic aorta model the same seems 
to be. true, as shown in the CsA-treated recipients. In the 
immunosuppressed animals the intimal lesions were less pro- 
nounced. This coincided with fewer infiltrating cells being pre- 
sent. However, in this group the antibody titre was also lower 
than in the control group. Therefore, we cannot exclude that 
humoral responses might also be responsible for the intimal 
proliferation that we observed. 
The pace of development of the arteriosclerotic lesions was 
higher in our aortic xenografts than in allografts. In various 
allogeneic combinations it has been reported that, up to 1 
month after transplantation, the intimal lesions in aortic grafts 
were absent or only minor,*‘-‘3 while in the xenogeneic model 
the intimal lesions were, by then, severe. This correlates with 
the findings of Reemtsma et al., who found that, in the cynom- 
olgus monkey-to-baboon heart transplantation model, the 
intimal lesion were already present after 6 days, while no 
intimal lesions could be found in the control allografts at that 
time.9 Their data were, however, not conclusive because they 
could not exclude that atherosclerotic lesions might have been 
present in the cynomolgus heart graft before transplantation. 
The results taken together strongly suggest that xenogeneic 
grafts are more prone to chronic rejection than allografts. 
Further studies are needed to determine whether this may be 
a problem for clinical xenotransplantation. 
Our results furthermore demonstrate that the development 
of arteriosclerotic lesions in xenografts can be inhibited by 
CsA. It is not clear what the effect of CsA is on this process 
in aortic allografts. The reported effects range from aggrava- 
tion,*’ via no influence’* to inhibition” of the process. The 
reported inhibition of chronic rejection in aortic allografts by 
CsA was partial at doses of 5 mg/kg given three times a week 
and complete at doses of 25 mg/kg given three times a week. 
This correlates with our findings in the xenogeneic model 
where a dose of 10 mg/kg given three times a week only 
inhibited the process. On the basis of this and on the basis of 
our histological and immunohistochemical data, we would like 
to suggest hat chronic rejection in concordant xenografts and 
allografts only differs in quantity and speed of development, 
but not in quality. 
In conclusion, arteriosclerosis, as a sign of chronic rejection, 
occurs in concordant aortic xenografts. The lesions in the 
xenografts develop extremely rapidly, and, compared to data 
from the literature, faster than in aortic allografts. The process 
of chronic rejection in xenografts can be reduced by CsA. 
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